InspireMD, Inc. (NSPR)

Market Cap	66.47M -17.1%
Revenue (ttm)	8.98M +28.1%
Net Income	-48.79M
EPS	-0.76
Shares Out	48.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,622
Open	1.370
Previous Close	1.350
Day's Range	1.370 - 1.420
52-Week Range	1.280 - 2.932
Beta	0.94
Analysts	Buy
Price Target	4.00 (+189.86%)
Earnings Date	May 8, 2026

About NSPR

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection syste...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 127
• Stock Exchange: NASDAQ
• Ticker Symbol: NSPR
• Website: https://www.inspiremd.com

Financial Performance

In 2025, InspireMD's revenue was $8.98 million, an increase of 28.11% compared to the previous year's $7.01 million. Losses were -$48.79 million, 52.4% more than in 2024.

Analyst Summary

According to one analyst, the rating for NSPR stock is "Buy" and the 12-month stock price target is $4.0.

Price Target

$4.0

(189.86% upside)

Analyst Consensus: Buy